| 000 | 01110 a2200289 4500 | ||
|---|---|---|---|
| 005 | 20250517050332.0 | ||
| 264 | 0 | _c20161230 | |
| 008 | 201612s 0 0 eng d | ||
| 022 | _a1996-3181 | ||
| 024 | 7 |
_a10.2174/1871527314666150821112228 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSharma, Ashish | |
| 245 | 0 | 0 |
_aExperimental Brain Ischemic Preconditioning: A Concept to Putative Targets. _h[electronic resource] |
| 260 |
_bCNS & neurological disorders drug targets _c2016 |
||
| 300 |
_a489-95 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aGlycogen Synthase Kinase 3 beta _xmetabolism |
| 650 | 0 | 4 |
_aHeat-Shock Proteins _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIschemic Preconditioning |
| 650 | 0 | 4 |
_aNeurodegenerative Diseases _xprevention & control |
| 650 | 0 | 4 |
_aOncogene Protein v-akt _xmetabolism |
| 700 | 1 | _aGoyal, Rohit | |
| 773 | 0 |
_tCNS & neurological disorders drug targets _gvol. 15 _gno. 4 _gp. 489-95 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2174/1871527314666150821112228 _zAvailable from publisher's website |
| 999 |
_c25190691 _d25190691 |
||